Terapia Asistida con Perros en niños y adolescentes con Trastorno del Espectro Alcohólico Fetal / Dog-Assisted Therapy for children and adolescents with Fetal Alcohol Spectrum Disorders

OBJETIVO: El objetivo de este estudio fue evaluar la eficacia de la Terapia Asistida con Perros (TAP) en niños y adolescentes con Trastorno del Espectro Alcohólico Fetal (TEAF). MÉTODO: Realizamos un ensayo piloto aleatorizado y controlado, cegado por el evaluador, en una cohorte de 33 niños y adolescentes con TEAF. Los participantes fueron asignados aleatoriamente al grupo TAP (n=17) o al tratamiento habitual (n=16). RESULTADOS: De los 39 participantes iniciales inscritos, 33 completaron el tratamiento. Un análisis de modelo de efectos mixtos reveló que los participantes que fueron asignados al grupo TAP experimentaron mejoras significativas en habilidades sociales (SSIS-P Habilidades sociales: p = 0.02; d = 0.8), reducciones en los síntomas de externalización (CBCL Externalización p = 0.03; d = 0.56) y puntuaciones más bajas en la severidad del TEAF (CGI-S Clínico: p = 0.001; d = 0.5). CONCLUSIONES: La TAP parece ser un tratamiento complementario prometedor para niños y adolescentes con TEAF

OBJECTIVE: The rationale of this study was to evaluate the efficacy of Dog Assisted Therapy (DAT) in children and adolescents with Fetal Alcohol Spectrum Disorder (FASD). METHOD: We conducted a randomized, rater-blinded, controlled pilot trial in a cohort of 33 children and adolescents with FASD. Participants were randomly assigned either to DAT group (n=17) or Treatment as Usual (TAU control group) (n=16). RESULTS: Of the initial 39 participants enrolled, 33 completed treatment. A mixed-effects model analysis revealed that participants who were assigned to the DAT group experienced significantly improvements on social skills (SSIS-P Social Skills: p = 0.02, d=0.8), reductions on externalizing symptoms (CBCL Externalizing: p = 0.03; d=0.56), and lower scores on FASD severity (CGI-S Clinician: p = 0.001, d=0.5). CONCLUSIONS: DAT is a promising adjunctive treatment for children and adolescents with FASD

Living with the animals: animal or robotic companions for the elderly in smart homes?

Although the use of pet robots in senior living facilities and day-care centres, particularly for individuals suffering from dementia, has been intensively researched, the question of introducing pet robots into domestic settings has been relatively neglected. Ambient assisted living (AAL) offers many interface opportunities for integrating motorised companions. There are diverse medical reasons, as well as arguments from animal ethics, that support the use of pet robots in contrast to living with live animals. However, as this paper makes clear, we should not lose sight of the option of living with animals at home for as long as possible and in conformity with the welfare of the animal assisted by AAL technology.

To What Extent Can the Use of a Mobility Assistance Dog Reduce Upper Limb Efforts When Manual Wheelchair Users Ascend a Ramp?

Biomechanical evidence is needed to determine to what extent the use of a mobility assistance dog (AD(Mob)) may minimize mechanical loads and muscular demands at the upper limbs among manual wheelchair users. This study quantified and compared upper limb efforts when propelling up a ramp with and without an AD(Mob) among manual wheelchair users. Ten manual wheelchair users with a spinal cord injury who own an AD(Mob) ascended a ramp with and without their AD(Mob). The movements of the wheelchair and upper limbs were captured and the forces applied at the pushrims were recorded to compute shoulder mechanical loading. Muscular demand of the pectoralis major, anterior deltoid, biceps, and the triceps was normalized against the maximum electromyographic values. The traction provided by the AD(Mob) significantly reduced the total force applied at the pushrim and its tangential component while the mechanical effectiveness remained similar. The traction provided by the AD(Mob) also resulted in a significant reduction in shoulder flexion, internal rotation, and adduction moments. The muscular demands of the anterior deltoid, pectoralis major, biceps, and triceps were significantly reduced by the traction provided by the AD(Mob). The use of AD(Mob) represents a promising mobility assistive technology alternative to minimize upper limb mechanical loads and muscular demands and optimize performance during wheelchair ramp ascent.

Using a Robotic Cat in Dementia Care: A Pilot Study.

The current study aimed to explore (a) reactions of individuals with dementia to an interactive robotic cat and their relatives' and professional caregivers' experiences, and (b) to measure usability in developing the care/treatment of individuals with dementia using interactive robotic pets. An intervention design in a pilot study using mixed methods was conducted in two stages: a quantitative single-case study (n = 4) and a qualitative interview study (n = 14). Results indicated less agitated behavior and better quality of life for individuals with dementia. Interviews showed positive effects by providing increased interaction, communication, stimulation, relaxation, peace, and comfort to individuals with dementia. The tested interactive robotic cat was also considered easy to use. There is an increased need for alternative/complementary forms of care to meet an increasing number of individuals with dementia. For some individuals with dementia, an interactive robot, such as a robotic cat, can increase well-being and quality of life.

Use of Robotic Pets in Providing Stimulation for Nursing Home Residents with Dementia.

Trial experiments utilized robotic pets to facilitate self-reliance in nursing home residents. A remote-control robot modeled clear and meaningful behaviors to elderly residents. Special attention was paid to its effects on mental and social domains. Employing the robot as a gaze target and center of attention created a cue to initiate a communication channel between residents who normally show no interest in each other. The Sony AIBO robot in this study uses commercially available wireless equipment, and all its components are easily accessible to any medical or welfare institution interested in additional practice of these activities.

Efectos de la terapia asistida con animales en personas con daño cerebral o lesión medular / Effects of animal assisted therapy in people with brain damage or spinal cord injury

Objetivo: Valorar los efectos terapéuticos obtenidos al aplicar un programa de terapia asistida con animales (TAA) en personas con daño cerebral o lesión medular. Material y método: Se realizó un estudio longitudinal prospectivo cuasi experimental en una población de 30 pacientes con diagnostico de daño cerebral o lesión medular. La selección se realizó mediante muestreo no probabilístico de conveniencia. Se dividieron en cinco grupos según criterios de edad. La duración del estudio fue de 16 meses, realizándose 23 sesiones de grupo, de 90 minutos de duración, durante los primeros nueve meses del estudio. Tres pacientes se perdieron durante el seguimiento. Para la evaluación se utilizó la Batería cognitiva LOTCA, el Índice de Barthel y la escala COPM. Resultados: En la valoración final, todos los pacientes mejoraron o se mantuvieron estables respecto a la valoración inicial. La evaluación COPM fue de 8,42±2,59 para la importancia, de 8,17±2,41 para el desempeño y de 8,96±2,07 en satisfacción. La valoración cognitiva mejoró en el 33% de los pacientes y la independencia funcional en el 37%. Conclusiones: La TAA puede servir como Técnica No Farmacológica (TNF) en los procesos de rehabilitación de las personas afectadas por patologías neurológicas (AU)

Objective: To evaluate the effects of animal assisted therapy (AAT) in a brain damaged or spinal injury population. Material and method: A prospective longitudinal study was undertaken on 30 patients with diagnosis of brain damage or spinal injury selected under non probabilistic accidental sampling, five groups were made according to patients age. A total of 23 sessions of AAT, 90 minutes long, were performed. Study period was 16 months, with therapy taking place in the first nine months. Three patients were lost in the follow up. Evaluation was performed using LOTCA cognitive battery test, Barthel index and COPM scale. Results: All patients showed improvement or no change according to initial evaluation. COPM evaluation were 8,42±2,59 for importance, 8,17±2,41 for performance, and 8,96±2,07 for satisfaction. Evaluation ranges from 1 to 10. Improvement was found in 33% of the patients for cognitive evaluation, and in 37% for functional independence evaluation showed improvement in most of the patients. Conclusion: AAT can be useful as non-pharmacological therapy in the rehabilitation process of neurological affected (AU)